SAVE-US Pivotal IDE Trial Enrollment Completed

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

Today Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today it has successfully completed enrollment of the SAVE-US (Surfacer® System to Facilitate Access in VEnous Occlusions – United States) pivotal trial evaluating the safety and efficacy of the Surfacer® Inside-Out® Access Catheter System in thirty patients across 7 U.S. centers. The trial demonstrated positive clinical results by meeting its primary and secondary endpoints.

The Surfacer System is a novel approach to achieving right-sided, upper body central venous access in patients with upper body venous occlusions or other conditions that preclude central venous access by conventional methods.

“I’m quite encouraged by the highly positive results demonstrated by the Surfacer System,” stated Mahmood Razavi, MD, Interventional Radiologist at St. Joseph Hospital in Orange, California and lead principal investigator of the SAVE-US study. “I am eager for the system’s commercial approval and look forward to offering a reliable and repeatable solution to patients with varying occlusion types, halting the devastating impact of central venous occlusive disease.”

Of the thirty patients enrolled in the US IDE SAVE-US trial, 90% met both the primary and secondary efficacy endpoints of facilitated central venous access by the Surfacer System. On average, central venous access was achieved in approximately 12 minutes despite a more complex patient population comprised largely of Type 3 and 4 occlusions (3 or more occluded vessels).

“The Surfacer System passed the SAVE-US study with flying colors, confirming the system is a safe, viable option for achieving right-sided central venous access, preserving secondary central veins,” stated Ehab Sorial, MD, Clinical Associate Professor of Surgery in the Division of Vascular Surgery at Stanford in California, staff surgeon at Santa Clara Valley Medical Center in San Jose, CA and the study’s second highest enroller. Dr. Sorial first learned about the Surfacer System while working alongside John Gurley, MD, the system’s inventor, for over a decade at the University of Kentucky. “This is a highly anticipated treatment that gives physicians a safe and effective alternative to other less efficacious treatments with higher complication rates. I am looking forward to its commercial approval and implementing it into my day-to-day practice.”

“I am grateful to the excellent team of physicians who contributed to the SAVE-US study’s outstanding success,” stated Gabriele Niederauer, Ph.D., CEO and President of Bluegrass Vascular. “I am eager to achieve the next major milestone of U.S. regulatory approval and anticipate that this hugely valuable treatment will be available to physicians and their patients in 2020.”

 

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.